Article
Clinical-Decision Criteria to Identify Recurrent Diabetic Macular Edema Patients Suitable…
Clinical Ophthalmology · 2020 · Adán A, Cabrera F, Figueroa MS, Cervera E, Ascaso FJ, Udaondo P, Abraldes M, Reyes MÁ, Pazos M, Pessoa B, Armadá F
Key facts
| Title | Clinical-Decision Criteria to Identify Recurrent Diabetic Macular Edema Patients Suitable for Fluocinolone Acetonide Implant Therapy (ILUVIEN®) and Follow-Up Considerations/Recommendations |
|---|---|
| First author | Adán A, Cabrera F, Figueroa MS, Cervera E, Ascaso FJ, Udaondo P, Abraldes M, Reyes MÁ, Pazos M, Pessoa B, Armadá F |
| Journal | Clinical Ophthalmology |
| Published | Jul 24, 2020 |
| DOI | 10.2147/OPTH.S252359 |
| Devices mentioned | K822706, K890514 |
| Product codes mentioned | HND, HPX, LKB |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1